Dr. A James Moser and his research team’s first goal is to establish the Minimally Invasive Pancreatic Surgery Registry to accumulate and analyze data from surgery for pancreatic cancer at 11 large hospitals across the country. This data sharing will allow researchers to accumulate significantly more data than has been possible in the past and draw much more reliable conclusions from it.
Once this database is underway, Dr. Moser’s aim is to link the genetic analysis of patient tumors removed surgically to patients’ survival. According to Dr. Moser, success in this area has been seen in the treatment of breast cancer, where a gene signature can now determine with tremendous accuracy whether or not a woman should be treated with chemotherapy.
The Alliance of Families Fighting Pancreatic Cancer will fund the genetic portion of the tumor analysis, which we hope will lead to improved treatments for pancreatic cancer patients.
View more info about the research we support.
View a presentation from Dr. Moser.